LZTS2 and prostate cancer: Deletion of the leucine zipper tumor suppressor 2 (Lzts2) that negatively regulates the Wnt pathway through β-catenin interactions has also been shown to synergize with Pten mono-allelic loss to induce early tumor onset and accelerate prostate cancer progression relative to single mutants [191].